Professional Documents
Culture Documents
Full download iPSCs for Studying Infectious Diseases (Volume 8) Alexander Birbrair (Ed.) file pdf all chapter on 2024
Full download iPSCs for Studying Infectious Diseases (Volume 8) Alexander Birbrair (Ed.) file pdf all chapter on 2024
https://ebookmass.com/product/trapped-brides-of-the-kindred-
book-29-faith-anderson/
https://ebookmass.com/product/neuroscience-for-neurosurgeons-
feb-29-2024_110883146x_cambridge-university-press-1st-edition-
farhana-akter/
https://ebookmass.com/product/genetics-and-evolution-of-
infectious-diseases-2nd-edition-michel-tibayrenc-editor/
https://ebookmass.com/product/gifts-glamping-glocks-a-camper-
criminals-cozy-mystery-series-book-29-tonya-kappes/
Comprehensive Review of Infectious Diseases 1st Edition
Andrej Spec
https://ebookmass.com/product/comprehensive-review-of-infectious-
diseases-1st-edition-andrej-spec-2/
https://ebookmass.com/product/comprehensive-review-of-infectious-
diseases-1st-edition-andrej-spec/
https://ebookmass.com/product/infectious-diseases-a-case-study-
approach-1st-edition-jonathan-cho/
https://ebookmass.com/product/critical-care-eeg-basics-rapid-
bedside-eeg-reading-for-acute-care-providers-
feb-29-2024_1009261169_cambridge-university-press-jadeja/
https://ebookmass.com/product/chronic-total-occlusions-a-guide-
to-recanalization-3e-nov-29-2023_1119517273_wiley-blackwell-ron-
waksman/
Advances in Stem Cell Biology
Series Editor
Alexander Birbrair
Advances in Stem Cell Biology
iPSCs for Studying
Infectious Diseases,
Volume 8
Edited by
Alexander Birbrair
Academic Press is an imprint of Elsevier
125 London Wall, London EC2Y 5AS, United Kingdom
525 B Street, Suite 1650, San Diego, CA 92101, United States
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
My father Lev Birbrair and my beloved mom Marina Sobolevsky of blessed memory (July 28, 1959eJune 3, 2020)
Contributors
Serkan Belkaya
Department of Molecular Biology and Genetics, Faculty of Science, Bilkent
University, Çankaya, Ankara, Turkey
David C. Bloom
Department of Molecular Genetics & Microbiology, University of Florida College of
Medicine, Gainesville, FL, United States
Guglielmo Bove
Schaller Research Group, Center of Infectious Diseases, Department of Virology,
Heidelberg University Hospital, Heidelberg, Germany
Adriana Bozzi
Instituto René Rachou, FIOCRUZ, Belo Horizonte, Brazil; Departamento de
Ciências Biológicas, Universidade Estadual de Santa Cruz, UESC, Ilhéus, Brazil
Kevin M. Coombs
University of Manitoba, Department of Medical Microbiology and Infectious
Diseases, Winnipeg, MB, Canada; Manitoba Centre for Proteomics & Systems
Biology, Winnipeg, MB, Canada; Children’s Hospital Research Institute of
Manitoba, Winnipeg, MB, Canada
Viet Loan Dao Thi
Schaller Research Group, Center of Infectious Diseases, Department of Virology,
Heidelberg University Hospital, Heidelberg, Germany
Matthew J. Demers
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States
Leonardo D’Aiuto
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States
Jessica L. Forbester
Division of Infection and Immunity/Systems Immunity University Research
Institute, Cardiff University, Cardiff, United Kingdom; MRC Weatherall Institute of
Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United
Kingdom
Eric C. Freundt
Department of Biology, The University of Tampa, Tampa, FL, United States
Sandra K. Halonen
Department of Microbiology and Immunology, Montana State University,
Bozeman, MT, United States
xiii
xiv Contributors
Brandon J. Kim
University of Alabama, Department of Biological Sciences, Tuscaloosa, AL,
United States
Paul R. Kinchington
Department of Ophthalmology, University of Pittsburgh School of Medicine,
Pittsburgh, PA, United States; Department of Molecular Microbiology and
Genetics, University of Pittsburgh, Pittsburgh, PA, United States
Thomas E. Lane
Department of Neurobiology & Behavior, University of California, Irvine, Irvine,
CA, United States
Jeanne F. Loring
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA,
United States
Laura L. McIntyre
Department of Molecular Biology & Biochemistry, University of California, Irvine,
Irvine, CA, United States
James McNulty
Department of Chemistry and Chemical Biology, McMaster University, Hamilton,
ON, Canada
Ann-Kathrin Mehnert
Schaller Research Group, Center of Infectious Diseases, Department of Virology,
Heidelberg University Hospital, Heidelberg, Germany
Vishwajit L. Nimgaonkar
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States
Warren C. Plaisted
Genomics Institute of the Novartis Research Foundation, San Diego, CA, United
States
Pavan Rajanahalli
Department of Biology, The University of Tampa, Tampa, FL, United States
Duncan R. Smith
Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom,
Thailand
David A. Stevens
California Institute for Medical Research, San Jose, CA, United States; Division of
Infectious Diseases and Geographic Medicine, Stanford University School of
Medicine, Stanford, CA, United States
Contributors xv
Craig M. Walsh
Department of Molecular Biology & Biochemistry, University of California, Irvine,
Irvine, CA, United States
Maribeth A. Wesesky
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States
Ali Zahedi-Amiri
University of Manitoba, Department of Medical Microbiology and Infectious
Diseases, Winnipeg, MB, Canada; Manitoba Centre for Proteomics & Systems
Biology, Winnipeg, MB, Canada
Wenxiao Zheng
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of
Pittsburgh School of Medicine, Pittsburgh, PA, United States; Department of
Psychiatry, The Second Xiangya Hospital, Xiangya School of Medicine, Central
South University, Changsha, China
About the editor
Alexander Birbrair
Dr. Alexander Birbrair received his bachelor’s biomedical degree from Santa Cruz
State University in Brazil. He completed his PhD in Neuroscience, in the field of
stem cell biology, at the Wake Forest School of Medicine under the mentorship of
Osvaldo Delbono. Then, he joined as a postdoc in stem cell biology at Paul
Frenette’s laboratory at Albert Einstein School of Medicine in New York. In
2016, he was appointed faculty at Federal University of Minas Gerais in Brazil,
where he started his own lab. His laboratory is interested in understanding how
the cellular components of different tissues function and control disease progression.
His group explores the roles of specific cell populations in the tissue microenviron-
ment by using state-of-the-art techniques. His research is funded by the Serrapilheira
Institute, CNPq, CAPES, and FAPEMIG. In 2018, Alexander was elected affiliate
member of the Brazilian Academy of Sciences (ABC), and in 2019, he was elected
member of the Global Young Academy (GYA). He is the Founding Editor and
Editor-in-Chief of Current Tissue Microenvironment Reports and Associate Editor
of Molecular Biotechnology. Alexander also serves in the editorial board of several
other international journals: Stem Cell Reviews and Reports, Stem Cell Research,
Stem Cells and Development, and Histology and Histopathology.
xvii
Preface
This book’s initial title was “iPSCs: Recent Advances.” Nevertheless, because of the
ongoing strong interest in this theme, we were capable of collecting more chapters
than would fit in one single volume, covering induced pluripotent stem cells (iPSCs)
biology from different perspectives. Therefore, the book was subdivided into
several volumes.
This volume “iPSCs for Studying Infectious Diseases” offers contributions by
known scientists and clinicians in the multidisciplinary areas of biological and
medical research. The chapters bring up-to-date comprehensive overviews of current
advances in the field. This book describes the use of iPSCs to model several
infectious diseases in vitro, enabling us to study the cellular and molecular
mechanisms involved in different infectious pathologies. Further insights into these
mechanisms will have important implications for our understanding of infectious
disease appearance, development, and progression. The authors focus on the modern
state-of-the-art methodologies and the leading-edge concepts in the field of stem cell
biology. In recent years, remarkable progress has been made in the obtention of
iPSCs and their differentiation into several cell types, tissues, and organs using
state-of-the-art techniques. These advantages facilitated identification of key targets
and definition of the molecular basis of several disorders. Thus, the present book is
an attempt to describe the most recent developments in the area of iPSCs biology,
which is one of the rising hot topics in the field of molecular and cellular biology
today. Here, we present a selected collection of detailed chapters on what we
know so far about the use of iPSCs for modeling multiple infectious diseases. Eleven
chapters written by experts in the field summarize the present knowledge about
iPSCs for studying infectious diseases.
Duncan R. Smith from Mahidol University gives a historical perspective on the
application of iPSCs in virology. Thomas E. Lane and colleagues from University of
California discuss the use of iPSCs in coronavirus-induced neurologic disease. Ali
Zahedi-Amiri and Kevin M. Coombs from University of Manitoba describe iPSCs
for modeling influenza infection. Leonardo D’Aiuto and colleagues from University
of Pittsburgh compile our understanding of iPSCs for modeling of herpes simplex
virus 1 infections. Serkan Belkaya from Bilkent University updates us with what
we know about iPSCs for modeling coxsackievirus infection. Eric C. Freundt and
Pavan Rajanahalli from The University of Tampa summarize current knowledge
on iPSCs to model Theiler’s murine encephalomyelitis virus infection. Viet Loan
Dao Thi and colleagues from Heidelberg University address the importance of iPSCs
for modeling of hepatotropic pathogen infection. Sandra K. Halonen from Montana
State University talks about the use of human iPSCs to study the neuropathogenesis
of Toxoplasma gondii. Adriana Bozzi and David A Stevens from Stanford University
focus on iPSCs for modeling Chagas disease. Brandon J Kim from the University of
Alabama presents the use of iPSCs to study hostepathogen interactions with
xix
xx Preface
Chapter outline
A brief history of virology ............................................................................................ 2
Viruses as obligate parasites....................................................................................... 2
The advent of cell biology ........................................................................................... 3
Stem cells, embryonic stem cells, and induced pluripotent stem cells ........................... 5
Current applications of iPSCs to virology...................................................................... 6
The family Caliciviridae .............................................................................................. 9
The family Coronaviridae........................................................................................... 10
The family Flaviviridae .............................................................................................. 11
The family Hepadnaviridae ........................................................................................ 13
The family Hepeviridae ............................................................................................. 13
The family Herpesviridae........................................................................................... 13
The family Orthomyxoviridae...................................................................................... 15
The family Paramyxoviridae....................................................................................... 15
The family Picornaviridae.......................................................................................... 16
The family Polyomaviridae......................................................................................... 16
The family Retroviridae ............................................................................................. 17
The family Togaviridae .............................................................................................. 17
Future directions....................................................................................................... 18
Acknowledgment....................................................................................................... 18
References ............................................................................................................... 18
Abstract
Viruses are obligate parasites in that they can only replicate within a living host
cell. Thus the science of virology is largely dependent upon the requirement to be
able to grow and propagate such host cells. While it is relatively simple to be able
to grow and maintain suitable host cells for viruses that infect prokaryotic cells, the
situation is more complicated when eukaryotic host cells are required for viral
propagation. Studies on eukaryotic viruses are thus often a compromise between
the ease of propagation of the host cell and the fidelity of the propagated cells to
the bona fide host cell. Until recently the choice was largely between primary cells
(high fidelity, low ease of propagation) or immortalized and transformed cells (low
fidelity, high ease of propagation). More recently, the discovery of induced
pluripotent stem cells (iPSCs), which have high fidelity and relatively high ease of
propagation, has introduced a third option. This chapter will present the historical
context of the application of iPSCs to questions in virology and describe how these
cells are currently being used.
human diploid cells. Hayflick proposed that normal somatic cells had an inherent
replication capacity of 40 þ 10 cells divisions, after which the cells become senes-
cent and die (Hayflick, 1965). This intrinsic replication capacity is now termed the
“Hayflick limit,” and in 2009, Blackburn, Greider, and Szostak shared the Nobel
Prize in Physiology or Medicine for their work on telomeres and telomerase, an
enzyme linked with the biological counting mechanism of cellular replication (Var-
ela and Blasco, 2010).
The Hayflick limit was proposed to explain the behavior of normal diploid cells,
as there were already cell lines that did not conform to this limit. The first bona fide
cell line capable of continuous culture was the mouse strain L, generated by W.R.
Earle in 1940 from mouse subcutaneous areolar and adipose tissue (Earle et al.,
1943). A clone from this strain (L929) generated in 1948 from the 95th subculture
was subsequently the first cloned cell line developed (Sanford et al., 1948). In the
following years, a number of immortalized or transformed cell lines capable of
continuous growth were produced, including HeLa (Scherer et al., 1953), CHO
(Tjio and Puck, 1958), MDCK (the isolation of this line was not published by Madin
and Darby, but it was subsequently used (Green, 1962) and characterized (Gaush
et al., 1966) by others), and WI-38 (Hayflick, 1965), the last of which was developed
by Hayflick himself.
Currently there are a large number of cell lines capable of continuous growth. A
main central repository for cell lines, the American Type Culture collection (ATCC),
maintains over 4000 cell lines. These cells are easy to propagate and expand and
have thus driven virus research for the last 60 or more years. Cell lines are either
immortalized or immortalized and transformed. Immortalized cells generally have
achieved stable telomeres through the expression of telomerase activity (Bodnar
et al., 1998), while transformed cells additionally have undergone neoplastic trans-
formation. In this regard, as these cells have acquired properties not normally
possessed by the corresponding primary cell, immortalized and transformed cells
cannot be considered as “normal” cells. In particular, transformed cells often express
proteins not normally found in the original cell type and conversely can fail to
express proteins that are normally expressed (Pan et al., 2009).
The ability of a virus to productively infect a particular cell depends upon the
susceptibility of the cell, as well as the permissiveness of the cell. Susceptibility
indicates that a particular virus can enter into a cell, while permissiveness indicates
that viral replication, packaging, and cellular egress can occur. In this regard, the
deranged protein expression found in immortalized and transformed cells can lead
to the derivation of susceptible and permissive cell lines from tissues that are not
normally target tissues of infection. Conversely, cell lines derived from a known
viral target tissue might be refractory to infection. Much of virology is therefore
dependent upon less than satisfactory model systems in which virus/cell line pair-
ings are based on utility, rather than being a reflection of true tropism. That said,
it should be noted that a similar criticism applies to studies on human pathogenic
viruses conducted in animals, in which the pathology may only poorly reflect the
pathogenesis seen in humans (Ruiz et al., 2017).
Stem cells, embryonic stem cells, and induced pluripotent stem cells 5
using the same factors (Takahashi et al., 2007), as well as by the group of James
Thompson using Oct4, Sox2, Nanog, and Lin28 (Yu et al., 2007). There is consider-
able research ongoing in developing iPSCs using different factors, cell types, and
protocols, as well as the development of protocols to differentiate iPSCs into
different cell types (Liu et al., 2020). However, crucially, the development and wide-
spread use of iPSCs put these cells into the hands of virologists who, for the first
time, were able to look at the cellular events ongoing during virus infection in a
cell line that could be differentiated into a bona fide cell type (See Fig. 1.2).
Hepatitis C virus (HCV), and Hepatitis B virus (HBV). The family Flaviviridae
accounted for over half of all studies, and ZIKV alone was the subject of a quarter
of all studies.